May 3, 2005-LifeTree eClinical, a member of the FFF Enterprises Inc. family of companies and a leading provider of clinical electronic data capture and analysis systems, today announced the launch of LifeTreeHub 1.0, an advanced platform for aggregating clinical trial documents, web-based messaging and virtual meeting capabilities.
TEMECULA, Calif., May 3, 2005-LifeTree eClinical, a member of the FFF Enterprises Inc. family of companies and a leading provider of clinical electronic data capture and analysis systems, today announced the launch of LifeTreeHub(tm) 1.0, an advanced platform for aggregating clinical trial documents, web-based messaging and virtual meeting capabilities.
A stand-alone, customizable portal, LifeTreeHub provides a secure electronic repository for the storage and retrieval of medical documents and clinical information, including regulatory documents, protocols, investigator CVs and medical licenses. The ability to version and digitally sign documents enhances the system's security. LifeTree ICTM(tm), an electronic data capture and analysis platform, is integrated with LifeTreeHub for a seamless transition from clinical functions to document sharing and retrieval. Used together, LifeTree ICTM and LifeTreeHub provide sponsors and clinical research organizations a comprehensive eClinical solution for their studies.
"I'm very pleased with our steady innovation," said Patrick M. Schmidt, CEO of LifeTree and FFF. "It reflects LifeTree's dedication to continually develop our suite of services and their delivery to our clients."
With LifeTreeHub, LifeTree's clients are easily able to aggregate the vast amount of complex information supporting clinical studies. According to Gary Gabriel, PhD, LifeTree's vice president of sales and business development, "LifeTreeHub is a major advancement for study sponsors and clinical research organizations that must achieve greater efficiency in their clinical trial projects. LifeTree's study portal serves as a hub for storing information about a trial and making it readily available to study sites and sponsors via the Internet. This helps streamline the study initiation, conduct and amendment processes. And the ability to connect clinical trial staff members through our virtual meeting capabilities adds to our mission of improving how individuals work and communicate within the clinical trial process."
About LifeTree eClinical
LifeTree eClinical, also known as LifeTree Technology LLC, is a member of the FFF Enterprises Inc. family of companies, headquartered in Temecula, California. The LifeTree suite of clinical technologies and services has been used in Phase I through IV trials, patient registries and diagnostic and epidemiological studies. LifeTree ICTM, the core technology of the LifeTree eClinical suite, provides tools for clinical study design, data entry and data reporting. The suite is completely workflow driven and contains extensive clinical trial metrics and trial management tools that are built-in for designated roles within the clinical trial process. SAS data on demand and a complete menu for building data reports fully empower a study's data analyst. LifeTree ICTM's newest features include comprehensive patient-safety reporting, medical coding and imaging data capabilities. The clinical data is fully audit trailed, and it is CDISC- and 21 CFR Part 11-compliant. For more information, call 800-211-2799 ext 1356, email info@lifetree-tech.com or visit www.lifetreeclinical.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.